Dr. Ayala Hubert
MD, Oncology & Radiotherapy
Head, Center for Treatment of Digestive Tract Cancer
corporate_fareHadassah Medical Center, Jerusalem
Ayala Hubert
MD, Oncology & Radiotherapy
Prof. Ayala Hubert is a senior gastrointestinal oncologist at Hadassah Medical Center in Jerusalem, Israel, where she heads the Center for Treatment of Digestive Tract Cancer. She also serves as Director of the Gastrointestinal Tumors Unit and Deputy Director of the Sharett Institute of Oncology at Hadassah.
With senior oncology roles at Hadassah dating to the late 1990s, Prof. Hubert has built one of Israel's most specialised digestive tract cancer programmes within the academic environment of the Sharett Institute of Oncology. Her clinical practice covers the full spectrum of gastrointestinal malignancies — colon, rectal, oesophageal, stomach, pancreatic, biliary tract, liver, small bowel and anal cancers — across pre-operative, adjuvant and metastatic stages. She works within a multidisciplinary model that brings together oncology, surgery, radiology, nuclear medicine and pathology teams to plan individualised treatment for each patient. Prof. Hubert has also contributed to PubMed-indexed research in locally advanced pancreatic cancer, KRAS-targeted investigational therapy, colorectal cancer genetics, gastric cancer systemic therapy and palliative management of malignant biliary obstruction.
CancerFax can coordinate medical-record review, second-opinion preparation and consultation support for international patients seeking care at Hadassah Medical Center.
Why Consider Prof. Ayala Hubert?
Prof. Ayala Hubert offers patients with complex digestive tract and pancreatic cancers access to specialised multidisciplinary oncology care at one of Israel's leading academic medical centres.
Areas of Specialisation
Comprehensive GI oncology expertise across the full spectrum of digestive tract and pancreatic cancers
Prof. Ayala Hubert's clinical specialisation covers all major digestive tract malignancies. Her practice spans systemic therapy, multidisciplinary treatment planning and research-aligned management of advanced and metastatic gastrointestinal and pancreatic disease.
Colorectal & Lower GI Cancer
Management of colon, rectal and anal cancers across all stages, including neoadjuvant, adjuvant and metastatic treatment strategies.
- arrow_rightPre-operative (neoadjuvant) chemotherapy for rectal cancer
- arrow_rightPost-operative adjuvant treatment for colon and rectal cancer
- arrow_rightSystemic therapy for metastatic colorectal cancer
- arrow_rightBiological and targeted therapy combinations where supported by biomarker profiling
- arrow_rightSystemic and multidisciplinary treatment planning for anal canal cancers
Pancreatic & Biliary Tract Oncology
Specialist management of pancreatic cancer, bile duct tumours, gallbladder cancer and liver cancer, including locally advanced and metastatic disease.
- arrow_rightSystemic chemotherapy for localised, locally advanced and metastatic pancreatic cancer
- arrow_rightClinical research involvement in KRAS-targeted investigational therapy for locally advanced disease
- arrow_rightMultidisciplinary planning including radiotherapy-based strategies in selected cases
- arrow_rightSystemic therapy for biliary tract and gallbladder cancers
- arrow_rightPalliative and supportive treatment planning for malignant biliary obstruction
- arrow_rightLiver-directed treatment coordination in selected cases
Upper GI & Small Bowel Cancers
Treatment planning for oesophageal, gastric and small bowel cancers, including neoadjuvant, adjuvant and metastatic approaches.
- arrow_rightNeoadjuvant and adjuvant systemic therapy for oesophageal cancer
- arrow_rightChemotherapy and biological therapy for gastric and gastroesophageal junction cancers
- arrow_rightSystemic treatment of metastatic upper GI tumours
- arrow_rightSystemic treatment planning for small intestine tumours as part of the GI cancer service
Procedures & Clinical Services
Treatment approaches and clinical services at Hadassah's digestive tract cancer centre
Prof. Hubert's clinical services span systemic cancer treatment, multidisciplinary planning, metastasis-directed coordination and specialist second-opinion review for gastrointestinal and pancreatic cancers.
Systemic Cancer Treatment
Medical OncologyChemotherapy, biological therapy and targeted therapy for digestive tract and pancreatic cancers across early, locally advanced and metastatic stages.
Multidisciplinary Treatment Planning
MultidisciplinaryCoordinated care planning involving oncology, surgery, radiology, nuclear medicine and pathology at Hadassah's digestive tract cancer centre.
Complex GI Cancer Management
Complex DiseaseSpecialist management of locally advanced and metastatic GI cancers including pancreatic, biliary tract and colorectal tumours.
Second Opinion for GI Cancer
Second OpinionSpecialist oncology review for patients with gastrointestinal or pancreatic cancer seeking an independent second opinion from an academic Israeli cancer centre.
Research & Publications
Clinical research contributions in gastrointestinal and pancreatic oncology
Prof. Ayala Hubert has contributed to clinical and translational research in gastrointestinal oncology, with a focus on locally advanced pancreatic cancer, KRAS-targeted therapy, colorectal cancer genetics, gastric cancer and biliary tract disease.
A full publication list is available via PubMed and Google Scholar. A more detailed list may be requested through the CancerFax coordination team.
Education & Training
Prof. Hubert completed her medical training at the Hebrew University–Hadassah Medical School in Jerusalem, followed by oncology and radiotherapy board certification in Israel and clinical fellowship training in the United States, including at UCSF, Stanford University and MD Anderson Cancer Center.
Clinical Experience
Prof. Ayala Hubert has been a senior oncologist at Hadassah University Hospital since 1998 and has headed the Center for Treatment of Digestive Tract Cancer since April 2009. She concurrently holds dual leadership roles as Director of the Gastrointestinal Tumors Unit and Deputy Director of the Sharett Institute of Oncology.
Languages & International
Prof. Ayala Hubert consults in the following languages.
CancerFax can coordinate professional medical interpreter support for international patients consulting through Hadassah Medical Center.
CancerFax can coordinate professional medical interpreter support for international patients where additional language assistance is required.
How CancerFax Helps You Access Dr. Ayala Hubert
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Ayala Hubert's team — with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history — prepared as a structured clinical summary for Dr. Ayala Hubert's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Ayala Hubert before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Ayala Hubert's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Ayala Hubert's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Ayala Hubert's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Prof. Ayala Hubert
Prof. Ayala Hubert specialises in gastrointestinal cancers including colon cancer, rectal cancer, oesophageal cancer, stomach cancer, pancreatic cancer, biliary tract cancer, liver cancer, small bowel cancer and anal cancer. She treats patients across all stages, including pre-operative, adjuvant and metastatic disease.
Prof. Ayala Hubert is based at Hadassah Medical Center in Jerusalem, Israel, where she heads the Center for Treatment of Digestive Tract Cancer. She also serves as Director of the Gastrointestinal Tumors Unit and Deputy Director of the Sharett Institute of Oncology.
Yes. Pancreatic cancer is a core area of her clinical practice. Prof. Hubert manages locally advanced, borderline resectable and metastatic pancreatic cancer, and has contributed to clinical research on KRAS-targeted investigational therapy for locally advanced pancreatic disease.
Hadassah Medical Center has an International Patient Department and accepts patients from outside Israel. CancerFax can coordinate medical-record review, case preparation and consultation support for international patients, subject to hospital availability and case acceptance.
Submit your medical reports, pathology results and imaging through CancerFax. The CancerFax team will review the documents, prepare a structured case summary and coordinate the next steps with Hadassah Medical Center, subject to availability. The final consultation format and appointment timeline are confirmed by the hospital.
The Center for Treatment of Digestive Tract Cancer at Hadassah offers chemotherapy, biological therapy, pre-operative and adjuvant treatment, metastatic disease management, and fully multidisciplinary planning with surgery, radiology, nuclear medicine and pathology teams. Liver-directed treatment and selected radiotherapy-based approaches may also be considered where clinically appropriate.
Connect with Ayala Hubert Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.